| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
adenosine deaminase | 0.440 | 0.885 | 2.9E-12 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2005 | 2005 | ||||||||
|
RNA, 28S ribosomal N5 | 0.705 | 0.346 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 1997 | 1997 | |||||||||
|
HOX transcript antisense RNA | 0.475 | 0.769 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2016 | 2016 | |||||||||
|
microRNA 147b | 0.736 | 0.423 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2014 | 2014 | |||||||||
|
microRNA 216b | 0.621 | 0.577 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | |||||||||
|
microRNA 942 | 0.695 | 0.500 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2014 | 2014 | |||||||||
|
microRNA 885 | 0.597 | 0.615 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | |||||||||
|
eosinophil granule ontogeny transcript | 0.743 | 0.346 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2016 | 2016 | |||||||||
|
SOD2 overlapping transcript 1 | 0.722 | 0.500 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2014 | 2014 | |||||||||
|
synaptonemal complex central element protein 1 like | 0.570 | 0.654 | 2.4E-14 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2001 | 2001 | ||||||||
|
CD24 molecule | 0.472 | 0.769 |
|
disease | 0.010 | None | 1.000 | 1 | 1 | 2015 | 2015 | |||||||||
|
cancer susceptibility 11 | 0.641 | 0.577 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | |||||||||
|
H3 histone pseudogene 20 | 0.890 | 0.154 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | |||||||||
|
microRNA 1247 | 0.604 | 0.500 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | |||||||||
|
microRNA 1231 | 0.736 | 0.308 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2016 | 2016 | |||||||||
|
microRNA 1304 | 0.711 | 0.423 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | |||||||||
|
TMED7-TICAM2 readthrough | 0.438 | 0.769 | 2.6E-03 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 1996 | 1996 | ||||||||
|
microRNA 3648-1 | 0.821 | 0.231 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | |||||||||
|
LY75-CD302 readthrough | 0.711 | 0.423 | 7.4E-46 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2015 | 2015 | ||||||||
|
RPL17-C18orf32 readthrough | 0.572 | 0.615 | 0.58 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2013 | 2013 | ||||||||
|
APOC4-APOC2 readthrough (NMD candidate) | 0.821 | 0.308 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2008 | 2008 | |||||||||
|
endogenous retrovirus group K member 10 | 0.729 | 0.346 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2011 | 2011 | |||||||||
|
endogenous retrovirus group K member 21, envelope | 0.729 | 0.346 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2011 | 2011 | |||||||||
|
promoter of MAT2A antisense radiation-induced circulating long non-coding RNA | 0.792 | 0.269 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2012 | 2012 | |||||||||
|
interleukin 18 binding protein | 0.603 | 0.731 | 1.5E-08 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2002 | 2002 |